|
Volumn 37, Issue 5, 1999, Pages 33-36
|
nablaRaloxifene to prevent postmenopausal osteoporosis
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COLESTYRAMINE;
ESTROGEN RECEPTOR;
RALOXIFENE;
TAMOXIFEN;
WARFARIN;
ANTIESTROGEN;
BONE MASS;
BREAST CANCER;
BREAST DISEASE;
CLINICAL TRIAL;
DRUG CONTRAINDICATION;
EOSINOPHILIA;
FEMALE;
HEPATITIS;
HIGH RISK POPULATION;
HOT FLUSH;
HUMAN;
POSTMENOPAUSE OSTEOPOROSIS;
RASH;
SHORT SURVEY;
UNITED KINGDOM;
UTERUS BLEEDING;
VEIN THROMBOSIS;
VERTEBRA FRACTURE;
REVIEW;
ESTROGEN ANTAGONISTS;
FEMALE;
HUMANS;
OSTEOPOROSIS, POSTMENOPAUSAL;
RALOXIFENE;
|
EID: 0033368695
PISSN: 00126543
EISSN: None
Source Type: Journal
DOI: 10.1136/dtb.1999.37533 Document Type: Short Survey |
Times cited : (8)
|
References (25)
|